It’s the active ingredient in Novo Nordisk’s Ozempic and Wegovy; Study done in comparison of seven popular diabetes medicines
Alzheimer's disease
Latest in Alzheimer's disease
Alzheimer
FDA approves Eli Lilly’s Kisunla for Alzheimer’s treatment
Becomes the second drug in market to slow down the dreaded memory-loss disease; Will cost $32,000 for a 12-month treatment
Alzheimer
Espresso coffee can help stop Alzheimer’s: scientists
Scientists study the impact of espresso coffee on Alzheimer’s
Alzheimer
Alzheimer’s disease medication Leqembi gets FDA’s Accelerated Approval
Developed by Eisai and Biogen, it slows down cognitive decline, but can also cause brain swelling and bleeding; to be priced at $26,500 for annual treatment